FDA Clears Siemens Prostate MR Solution

January 29, 2016 — The U.S. Food and Drug Administration (FDA) has cleared the noninvasive SEEit prostate magnetic resonance (MR) imaging solution from Siemens Healthcare. Powered by syngo MR E11 software architecture, SEEit enables users of Siemens’ high-performance Magnetom Aera 1.5 Tesla (1.5T) and Magnetom Skyra 3T MRI systems to perform a routine prostate exam in just 10 minutes without using an endorectal coil, which can cause patient discomfort.

Siemens’ Direct RF and high-density coil technology Tim 4G – coupled with its Resolve diffusion technology – deliver the signal-to-noise ratio (SNR) and resolution that enable users to perform these examinations using only the company’s new Body 30/60 surface coil.

For more information: www.usa.healthcare.siemens.com